This message was sent to ##Email##
|
| October 22, 2015 |
| |  | | |
|
|
|
ITNS
ITNS has one remaining $2,500 grant available. The purpose of this grant is to encourage qualified ITNS members to advance the body of transplant knowledge. This grant may be used to support research projects, a systematic review of the literature, a meta-analysis, a quality improvement initiative or a program evaluation project. Additional information and the grant application form are available on the ITNS website: http://www.itns.org/researchgrants.html
ITNS
This handbook is designed as a general reference for care after kidney transplantation. Transplant centers often have different care routines, monitoring guidelines, and immunosuppressive routines following kidney transplant. You can purchase a PDF download (limited to 3 downloads per purchase) of the handbook in the ITNS online store. Review the Table of Contents and purchase your handbook. Members pay only $5!
The Huffington Post
So far this year, 18,048 people (and counting) have received organ transplants. Another 122,586 people are in need of a lifesaving organ transplant, with no choice but to add their name to a waiting list and hope for a donor.
What if, instead of 122,586 people, that number was zero? Thanks to serious advancements in medical technology, that's an increasingly possible scenario. But when? Depends what technology you're referring to, and whom you ask.
READ MORE
Puget Sound Business Journal
UW Medicine has performed the first U.S. transplant of a heart that was kept pumping blood outside of a human body using innovative new transplant technology.
UW Medicine's Regional Heart Center, along with six other medical programs in the U.S., is conducting a clinical trial for a medical device called OCS Heart, which has come to be called "heart in a box," developed by Andover, Mass.-based medical device company TransMedics.
READ MORE
Pharma Biz
Shire plc has announced that the United States Food and Drug Administration (FDA) has granted Fast Track designation for the investigation of Cinryze (C1 esterase inhibitor [human]) for intravenous administration in subjects with antibody mediated rejection (AMR) in renal transplant recipients.
Cinryze is being studied as an adjunct treatment to donor specific antibodies (DSA) reduction therapy in kidney transplant patients with acute AMR.
READ MORE
UC San Diego Health
A teenage girl faced with sudden rapid heart deterioration, a man in the prime years of his life suffering from debilitating heart failure and a former NFL athlete crippled by end-stage heart failure were all successfully treated with a surgical approach pioneered by cardiac experts at University of California, San Diego School of Medicine.
READ MORE
Live Science
Every 10 minutes, another name goes on the list of Americans waiting for an organ transplant. Most of those patients will have to wait months or even years before finding a donor organ, and unfortunately, some never will. By the end of the day, 22 more people will die while awaiting a donor organ.
The problem is, there simply aren't enough donors to meet demand.
READ MORE
Gizmodo
Two research teams in the last few months have published studies on kidney structures grown from stem cells, which might be a step toward personalized replacement organs grown from patients’ own cells.
“We have converted skin cells to stem cells and developed a highly efficient process to convert these stem cells into kidney structures that resemble those found in a normal human kidney,” biologist Ryuji Morizane of Brigham and Women’s Hospital, lead author of a new study in the journal Nature Biotechnology, said in a statement.
READ MORE
Lymphoma News Today
Recently, a group of clinical researchers from Johns Hopkins Hospital (JHH) released study results revealing that the immunosuppressive drug mycophenolate mofetil (MMF) may be linked to an increased risk of central nervous system (CNS) lymphoma in solid organ transplant (ie. liver transplant) patients. The study, entitled, “Primary CNS lymphoproliferative disease, mycophenolate and calcineurin inhibitor usage,” was published in the latest edition of the journal Oncotarget.
READ MORE
Motley Fool
After decades of studying marijuana's potential risks, the scientific community is making a great effort to understand all of the possible benefits it could offer. This is no great surprise, considering the overwhelming support the marijuana industry now has from the American public. But the primary focus on marijuana recently has been its safety and benefits profile. Countless studies have emerged showing a correlation between marijuana use and reduced symptoms and severity associated with select diseases.
Recently, we learned of an entirely new potential benefit of marijuana: organ transplant rejection delay.
READ MORE
By Joan Spitrey
According to most projections, the United States will need at least 500,000 nurses by 2022. However, when taking into account retirement and attrition of staff, that number quickly escalates to 1.5 million nurses that will be needed nationally.
The need for nurses is not only an American problem. A World Health Organization report in 2010 described a growing need for nurses around the globe. The need is present in all countries — rich or poor.
So what is causing this great need, and how will it be met?
READ MORE
CBS News
Three people who received organ transplants from the same donor all developed serious brain problems shortly after their operations. The mysterious symptoms turned out to be due to a little-understood parasite that infected the donor before she died, according to a new report of the case.
READ MORE
|
Missed last week's issue? See which articles your colleagues read most.
|
|
Don't be left behind. Click here to see what else you missed.
|
|
|
|
|
|
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
